BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 34332771)

  • 1. From bench side to clinic: Potential and challenges of RNA vaccines and therapeutics in infectious diseases.
    Pandey M; Ojha D; Bansal S; Rode AB; Chawla G
    Mol Aspects Med; 2021 Oct; 81():101003. PubMed ID: 34332771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Insight on RNA Based Therapeutics and Vaccines: Challenges and Opportunities.
    Batra K; Maan S; Sehrawat A
    Curr Top Med Chem; 2021; 21(32):2851-2855. PubMed ID: 34792013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress on RNA-based therapeutics for genetic diseases.
    Luo T; Huo C; Zhou T; Xie S
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 52(4):406-416. PubMed ID: 37643975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The infinite possibilities of RNA therapeutics.
    Mollocana-Lara EC; Ni M; Agathos SN; Gonzales-Zubiate FA
    J Ind Microbiol Biotechnol; 2021 Dec; 48(9-10):. PubMed ID: 34463324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumoral RNA-targeted oligonucleotide therapeutics: The third pillar after small molecule inhibitors and antibodies.
    Taniguchi H; Suzuki Y; Imai K; Adachi Y
    Cancer Sci; 2022 Sep; 113(9):2952-2961. PubMed ID: 35701833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA Therapeutics: How Far Have We Gone?
    Coutinho MF; Matos L; Santos JI; Alves S
    Adv Exp Med Biol; 2019; 1157():133-177. PubMed ID: 31342441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small non-coding RNA therapeutics for cardiovascular disease.
    Shah AM; Giacca M
    Eur Heart J; 2022 Nov; 43(43):4548-4561. PubMed ID: 36106499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA therapeutics: RNAi and antisense mechanisms and clinical applications.
    Chery J
    Postdoc J; 2016 Jul; 4(7):35-50. PubMed ID: 27570789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver as a target for oligonucleotide therapeutics.
    Sehgal A; Vaishnaw A; Fitzgerald K
    J Hepatol; 2013 Dec; 59(6):1354-9. PubMed ID: 23770039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Small RNA Landscape in NSCLC: Current Therapeutic Applications and Progresses.
    Ciccone G; Ibba ML; Coppola G; Catuogno S; Esposito CL
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current RNA-based Therapeutics in Clinical Trials.
    Zhou LY; Qin Z; Zhu YH; He ZY; Xu T
    Curr Gene Ther; 2019; 19(3):172-196. PubMed ID: 31566126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in the delivery of RNA therapeutics: from concept to clinical reality.
    Kaczmarek JC; Kowalski PS; Anderson DG
    Genome Med; 2017 Jun; 9(1):60. PubMed ID: 28655327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The development and improvement of ribonucleic acid therapy strategies.
    Zhao Y; Shu R; Liu J
    Mol Ther Nucleic Acids; 2021 Dec; 26():997-1013. PubMed ID: 34540356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA therapeutics history and future perspectives.
    Duong HQ; Hoang MC; Nguyen TH; Ngo VL; Le VT
    Prog Mol Biol Transl Sci; 2024; 203():99-114. PubMed ID: 38360008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA therapeutics: updates and future potential.
    Zhang C; Zhang B
    Sci China Life Sci; 2023 Jan; 66(1):12-30. PubMed ID: 36100838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Types of RNA therapeutics.
    Goleij P; Babamohamadi M; Rezaee A; Sanaye PM; Tabari MAK; Sadreddini S; Arefnezhad R; Motedayyen H
    Prog Mol Biol Transl Sci; 2024; 203():41-63. PubMed ID: 38360005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frameworks for transformational breakthroughs in RNA-based medicines.
    Androsavich JR
    Nat Rev Drug Discov; 2024 Jun; 23(6):421-444. PubMed ID: 38740953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA therapeutics for metabolic disorders.
    Vu TD; Lin SC; Wu CC; Chu DT
    Prog Mol Biol Transl Sci; 2024; 203():181-196. PubMed ID: 38359998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA-based therapeutics: current progress and future prospects.
    Burnett JC; Rossi JJ
    Chem Biol; 2012 Jan; 19(1):60-71. PubMed ID: 22284355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oligonucleotide antiviral therapeutics: antisense and RNA interference for highly pathogenic RNA viruses.
    Spurgers KB; Sharkey CM; Warfield KL; Bavari S
    Antiviral Res; 2008 Apr; 78(1):26-36. PubMed ID: 18258313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.